| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8215251 | International Journal of Radiation Oncology*Biology*Physics | 2016 | 7 Pages |
Abstract
Results of this study suggest that the RECQ1 A159C genotype may be a prognostic or predictive factor for resectable pancreatic cancer patients who are treated with adjuvant 5-FU before and after 5-FU-based chemoradiation. Further study is needed in patients treated with gemcitabine to determine whether an association exists.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Donghui PhD, Jennifer MS, Christopher MD, John P. MD, William F. MD, Ross A. MD, Howard MD, Chang MD, Ping MD, Gary M. MD, Kathryn A. MS, Chandan MD, James L. MD,